IP Verse

Formulations Of 4-Amino-2-(2,6-Dioxopiperidine-3-Yl)Isoindoline-1,3-Dione

Patent No. EP3351240 (titled "Formulations Of 4-Amino-2-(2,6-Dioxopiperidine-3-Yl)Isoindoline-1,3-Dione") was filed by Celgene on May 19, 2010. The application was issued on Apr 10, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
HOFFMANN EITLEJan 10, 2020HOFFMANN EITLE
GENERICS UKJan 9, 2020ELKINGTON AND FIFE
HGFJan 8, 2020HGF
PRUSSDec 16, 2019HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3351240

CELGENE
Application Number
EP18160247A
Filing Date
May 19, 2010
Status
Revoked
Feb 25, 2025
Publication Date
Apr 10, 2019
External Links
Slate, Register , Google Patents